
WVU researcher prototypes new equipment to improve head and neck cancer treatment
WVUToday
Head and neck cancer may not be as common as breast or prostate cancer, but it’s one of the most challenging to treat. Its five-year survival rate can be as low as 25%, while its recurrence rate can be as high as 43%.
West Virginia U